Erfassung der APC-Response über die Inaktivierung von Faktor Villa: ein neuer chromogener Test

  • B. Moritz
  • K. Váradi
  • H. P. Schwarz
  • H. Lang
Conference paper

Zusammenfassung

In der Blutgerinnung haben antikoagulatorische Mechanismen eine wichtige regulatorische Funktion. Einer dieser Mechanismen ist der Protein-C(PC)-Pathway, der die Inaktivierung von Faktor Villa und Faktor Va durch aktiviertes PC (APC) bewirkt. Diese Bedeutung wurde in den letzten eineinhalb Jahren verstärkt erkannt.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Dahlbäck B, Carlsson M, Sevensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated Protein C: Prediction of a cofactor to activated Protein. Proc Natl Acad Sci USA 90:1004–1008PubMedCrossRefGoogle Scholar
  2. 2.
    Dahlbäck B, Hildebrand B (1994) Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 91:1396–1400PubMedCrossRefGoogle Scholar
  3. 3.
    Shen L, Dahlbäck B (1994) Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor Villa. J Biol Chem 269:18735–18738PubMedGoogle Scholar
  4. 4.
    Griffin JH, Evatt BL, Wideman C, Fernandez JA (1993) Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82:1989 – 1993Google Scholar
  5. 5.
    Halbmayer W-M, Haushofer A, Schön R, Fischer M (1994) The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coag Fibrinol 5:51–57CrossRefGoogle Scholar
  6. 6.
    Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:8886 – 8887CrossRefGoogle Scholar
  7. 7.
    Svensson PJ, Dahlbäck B (1994) Resistance to activated Protein C as a basis for venous thrombosis. N Engl J Med 330:517 – 522PubMedCrossRefGoogle Scholar
  8. 8.
    Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, Van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64 – 67PubMedCrossRefGoogle Scholar
  9. 9.
    Beauchamp NJ, Daly ME, Hampton KK, Cooper PC, Preston FE, Peake IR (1994) High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis. Br J Haematol 88:219 – 222PubMedCrossRefGoogle Scholar
  10. 10.
    Comp CP, Nixon RR, Cooper MR, Esmon CT (1984) Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 74:2082–2088PubMedCrossRefGoogle Scholar
  11. 11.
    Moritz B, Halbmayer W-M, Lang H, Fischer M (1994) Possible interaction of APC response on clotting protein S assays. Annals Hematol [Suppl II]: A112 (abstract)Google Scholar
  12. 12.
    Halbmayer W-M, Haushofer A, Schön R, Fischer M (1994) Influence of Lupus Anticoagulant on a commercially available kit for APC-Resistance. Thromb Haemo 724: 645–646Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • B. Moritz
  • K. Váradi
  • H. P. Schwarz
  • H. Lang

There are no affiliations available

Personalised recommendations